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ABSTRACT
Objective: In this study, to evaluate the computational studies of eriodictyol docked with apoptotic proteins.
Methods: AutoDock Vina and Molecular Graphics Laboratory tools were used to determine the interaction between proteins and eriodictyol. 
Discovery studio visualizer and PyMOL were used to determine the interaction of amino acid residues between apoptotic proteins and eriodictyol.
Results: The obtained results revealed more binding affinities of p53, caspase 8, B-cell lymphoma (Bcl)-2, Bcl-2 - associated X protein (BAX), and 
adenomatous polyposis coli (APC) of −10.6, −10.9, −9.0, −9.5, and 7.2 kcal/mol, respectively. Interaction of hydrophobic polar contacts of amino acid 
residues of p53 (CYS-277 and ALA-276), caspase 8 [THR-467, THR-337 (2), and GLU-396 (2)], Bcl-2 [ARG-103 (3), ALA-104 (2), and PHE-105, TYR-
101], BAX [GLY-108, TRY-107, ASN-106, and GLN-155 (2)], and APC [GLU-40 (2) and LEU-37 (2)] were notified between macromolecules and small 
molecules. The calculation of root-mean-square deviation of proteins and eriodictyol showed the lower binding energies to be 11.6, 12.5, 15.9, 19.6, 
and 15.8 and the upper binding energies to be 12.4, 15.3, 16.9, 20.7, and 18, respectively. The homology of binding energies was determined below 2Å 
which is computationally less expensive and easily determined the hydrophobic polar contacts.
Conclusions: The homology of binding energies was determined below 2Å which is computationally less expensive and easily determined 
the hydrophobic polar contacts. The results were proved that the eriodictyol highly interacted with apoptotic proteins. It might be a strong 
anti-inflammatory activity of colon cancer. In future, computational molecular docking studies should aid further in vitro and in vivo studies.
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INTRODUCTION
Colorectal adenocarcinoma is one of the leading causes of morbidity 
and mortality in the Western world [1]. Currently, an urgent need exists 
for the discovery and development of novel preventive and therapeutic 
strategies to combat the severity of the colon cancer. The American 
Cancer Society has estimated the epidemiological data of colon cancer 
to be 95,270 new cases and 49,190 deaths in 2016 [2]. In colon cancer 
treatments, the surviving drugs are proving in inhibiting the molecular 
targets, particularly by novel agents [3]. Eriodictyol is a strong flavonoid 
extracted from Eriodictyon californicium and is also called as California 
yerba santa [4]. It exhibits well-known antioxidant, anti-inflammatory, 
antineoplastic, antimicrobial, and antinociception activities (Fig.1) [5-8].
Mitochondria, the powerhouse of the cell, play a key role in the 
regulation of apoptosis and signaling and cellular differentiation. In 
mitochondria, cytochrome c causes the release of an apoptosis-inducing 
factor, activation of Bcl-2 - associated X protein (BAX), biological down-
regulation of B-cell lymphoma (Bcl)-2, and release of molecules involved 
in reactive oxygen species [9]. In addition, p53 consists of N-terminal 
activation domain, a basic DNA-binding domain with residues within 
100-300, and C-terminal basic domain, residues 356-393 [10,11]. The 
amino acid residues are involved in the activation of p53 in cell cycle 
arrest that includes DNA repair and apoptosis [12].
Computationally, biological interaction with proteins, resulting in 
suppression of apoptosis is frequently linked with increased expression 
of anti-apoptotic proteins and decreased expression of pro-apoptotic 
proteins [13]. Insight of protein interactions by three-dimensional (3D) 
structural studies of anti-apoptotic Bcl-2 family [14] reveal an important 
role in mitochondria pathways-mediated apoptosis; in this, amino acid 
residues interact with many kinds of small molecules [15], and the 
overexpression of anti-apoptotic protein is induced [16] in various 
cancer cells, including colon cancer. Colon cancer leads to mutation [17] 
in wnt/beta catenin pathway [18] molecules, such as beta catenin and 
adenomatous polyposis coli (APC). In addition, the APC gene molecular 
lesions are observed in the majority of familial AP [19] and it regulates a 
number of cellular functions, which include mitosis, migration, and the 
maintenance of genome stability [20].
Molecular docking is a computational technique that predicts the 
noncovalent interaction between two macromolecules or more repeatedly 
in a macro and small molecules [21]. Drug discovery, molecular docking, 
and virtual screening, offering multi-user capability, enhanced accuracy, are 
performed by AutoDock Vina; it is a new open-source program. This software 
was executed by Dr. Oleg Trott in the Molecular Graphics Laboratory (MGL) 
at the Scripps Research Institute. AutoDock Vina significantly enhances 
the average accuracy of the binding mode predictions, scoring functions, 
optimization algorithm, and implementations [22].
This study evaluated interaction of amino acid residues from different 
types of proteins and root-mean-square deviation (RMSD) differentiation 
of lower binding and upper bindings of eriodictyol with proteins using 
the docking score. With this background, this study was estimated in 
eriodictyol might be acting as colonic tumor suppressor gene like APC 
and other apoptotic proteins in computational docking studies.
METHODS
Molecular docking studies
3D crystallographic structures of proteins were obtained from 
Protein Data Bank (PDB) (http://www.pdb.rcsb.org), and those of 
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small molecules were retrieved from PubChem compound database 
(http://www.ncbi.nlm.nih.gov/search). Molecular docking studies 
were done using AutoDock Vina, version 1.1.2, of the MGL at the 
Scripps Research Institute. MGL tool, version 1.5.6, from MGL at the 
Scripps Research Institute, was used for visualization and analysis 
of molecular structures. Other software used were Discovery Studio 
Visualizer 3.5, downloaded from BIOVIA community, Q-site finder 
(ligand binding site prediction), and PyMOL 1.3 Molecular Graphics 
System.
Preparation of proteins and ligands
The 3D structures of proteins were retrieved as follows: p53 from PDB 
ID: 1 TUP; caspase 8, PDB ID: 2Y1L; Bcl-2, PDB ID: 1MAZ; BAX, PDB ID: 
1F16; APC, PDB ID: 1DEB. Initially, DNA, ligand, and crystallographic 
water molecules were removed in the 3D structure using Discovery 
Studio Visualizer; AutoDock Tools assigned polar hydrogen, Kollman 
United atom charges, salvation parameters, and fragmental volumes to 
the protein. AutoDock saved the prepared protein file in PDBQT format. 
The 3D structure of eriodictyol saved in SDF format was converted 
to PDB format, and using MGL tools, hydrogen atoms were added to 
check the valencies of the heavy atoms. The ligand was minimized by 
computing Gasteiger charges and saved in PDBQT format.
Grid generation and molecular docking
The auto grid was used for the preparation of the grid map using a 
grid box. Points on a 3D grid were placed to cover the complete inner 
cavity of the receptor that constitutes the ligand. The grid size was set 
to 40×40×40 xyz points with grid spacing of 0.375 A° and grid center 
was designed at dimensions (x, y, and z): 58.176, 15.383, and 78.349 
(PDB ID: 1TUP); −3.42, 17.15, and −31.714 (PDB ID: 2Y1L); 1.936, 
22.227, and 39.275 (PDB ID: 1MAZ); 1.0125, 4.0125, and −1.0125 (PDB 
ID: 1F16); and 44.052, 7.925, and 3.108 (PDB ID: 1DEB), respectively. 
A scoring grid was computed using the ligand structure to reduce the 
computation time. Docking was carried out using AutoDock Vina with 
protein and ligand data together with the grid box properties in the 
configuration file. It uses iterated local search global optimizer with 
the AMBER force field. Throughout the docking studies, the protein 
molecule was kept as rigid and ligand molecules as flexible.
The results <2.0Å in positional RMSD were grouped together, and the 
outcome with the most favorable free energy of binding was used for 
representation. The pose with lowest binding energy or binding affinity 
was used for subsequent analysis.
RESULTS AND DISCUSSION
Binding affinity
AutoDock Vina with combined optimization algorithm was performed 
in molecular docking [23]. Binding energy scoring with AutoDock Vina 
is generally designed to reduce computing costs and used to estimate 
large numbers of receptors-ligand complexes [24]. In these receptor-
ligand interactions, the prediction of binding energy was evaluated by 
free energy simulation techniques [25]. We first developed binding 
energy scoring function of eriodictyol docked with different types of 
tumor suppressor proteins and apoptotic proteins. The computational 
analysis of this drug was the first time to understand the mechanism 
of interaction [26] between eriodictyol and apoptotic proteins. 
Table 1 shows the values for p53, caspase 8, Bcl-2, BAX, and APC to 
be −10.6, −10.9, −9.0, −9.5, and −7.2 kcal/mol, respectively. All the 
proteins were having high affinity and strongly bonded with polar 
contacts (Fig. 2). The results proved that eriodictyol highly interacted 
with the colon cancer tumor suppressor gene of APC.
Interaction of amino acid residues
The interaction linking of amino acids in proteins has been explored 
for several decades using knowledge-based approaches and amino 
acids making contact with the hydrophobic interaction into small 
molecules [27]. During the folding process of amino acids, all water 
molecules were removed from the functional group of proteins for 
finding out the binding energy [28], the polar and nonpolar amino 
acid residues were interacted with eriodictyol. Table 2 shows that 
p53 contains CYS-277 and ALA-276; caspase 8 contains THR-467, 
THR-337 (2), and GLU-396 (2); Bcl-2 contains ARG-103 (3), ALA-
104 (2), PHE-105, and TYR-101; BAX contains GLY-108, TRY-107, ASN-
106, and GLN-155 (2); APC contains GLU-40 (2) and LEU-37 (2).
RMSD calculations
RMSD was used for the assessment of docking accuracy of the fraction 
of protein-ligand contacts [29] and the successful prediction of RMSD 
<2 Å [30]. The RMSD prediction was evaluated from the lower and 
upper binding energies of proteins with eriodictyol.  Fig. 3 shows the 
calculation of RMSD for target proteins of p53, caspase 8, Bcl-2, BAX, 
and APC, with the lower binding energy of 11.6, 12.5, 15.9, 19.6, and 
15.6 and upper binding energies of 12.4, 15.3, 16.9, 20.7, and 18.0, 
respectively. In AutoDock Vina, we measured 3D structure by RMSD 
in optimal rigid body superposition. The quantitative comparison 
between protein and ligand was performed; the predicted structure of 
folded protein and ligand was also calculated.
Table 1: Predicted free energy of∆G proteins with eriodictyol
Ligand Target proteins‑G‑score (kcal/mol)
Eriodictyol p53 Caspase 8 Bcl‑2 BAX APC
−10.6 −10.9 −9.0 −9.5 −7.2
Bcl-2: B-cell lymphoma-2, BAX: Bcl-2 - associated X protein, APC: Adenomatous 
polyposis coli
Table 2: Interacted amino acid residues of proteins with eriodictyol
Ligand Target proteins‑interacting amino acid residue (s)
Eriodictyol p53 Caspase 8 Bcl‑2 BAX APC
CYS-277 THR-467 ARG-103 (3) GLY-108 GLU-40 (2)
ALA-276 THR-337 (2) ALA-104 (2) TRY-107 LEU-37 (2)
GLU-396 (2) PHE-105 ASN-106
TYR-101 GLN-155 (2)
Bcl-2: B-cell lymphoma-2, BAX: Bcl-2 - associated X protein, APC: Adenomatous polyposis coli
Fig. 1: The molecular structure of eriodictyol
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CONCLUSION
Molecular docking was well identified in computational studies using 
the AutoDock Vina. In this study, we have evaluated the interaction 
of five macromolecules with the small molecule of eriodictyol, which 
bounded well and possessed a high score of binding affinity; calculation 
of RMSD in below 2 Å and the determination of specific amino acid 
residues that interacted with the small molecule were also identified. 
The results proved that the small molecules can strongly interact with 
apoptotic and tumor suppressor genes and binding scores of colonic 
suppressor proteins showed high affinity when interacted with the 
small molecule. The novelty of this study was estimated in APC act a 
tumor suppressor gene in colon cancer, the docking results proved 
that eriodictyol interacted with five different proteins, but the APC 
gene having more affinity compared than other genes. In addition to 
this, with the help of these results, it was proved that eriodictyol also 
has anti-inflammatory activity in colon cancer. Future studies should 
estimate the interaction of eriodictyol with colon cancer apoptotic 
pathways in both in vitro and in vivo.
REFERENCES
1. Karthi N, Manju V. Synergistic effects of selected anticancer drugs with 
vitamin-E against HT-29 human adenocarcinoma cell lines. Indian J 
Res Pharm Biotechnol 2014;2(1):1246-53.
2. Cancer Facts and Figures. The American Cancer Society, 2016. 
Available from: http://www.cancer.org.
3. Coker-Gurkan A, Arisan ED, Obakan P, Guvenir E, Unsal NP. 
Inhibition of autophagy by 3-MA potentiates purvalanol-induced 
apoptosis in Bax deficient HCT 116 colon cancer cells. Exp Cell Res 
2014;328(1):87-98.
4. Bucolo C, Leggio GM, Drago F, Salomone S. Eriodictyol prevents early 
retinal and plasma abnormalities in streptozotocin-induced diabetic 
rats. Biochem Pharmacol 2012;84(1):88-92.
5. Hu Q, Zhang DD, Wang L, Lou H, Ren D. Eriodictyol-7-O-glucoside, 
a novel Nrf2 activator, confers protection against cisplatin-induced 
toxicity. Food Chem Toxicol 2012;50(6):1927-32.
6. Huang TC, Tseng KY, Tsai SS, Liu HJ, Ho CH, Lin HY, et al. Eriodictyol 
decreases very late antigen-4 (VLA-4) expression, cellular adhesion, 
and migration through an NF kB-dependent pathway in monocytes. 
J Funct Foods 2012;2:263-70.
7. Imen MB, Chaabane F, Nadia M, Soumaya KJ, Kamel G, Leila CG. 
Anti-melanogenesis and antigenotoxic activities of eriodictyol in 
murine melanoma (B16-F10) and primary human keratinocyte cells. 
Life Sci 2015;135:173-8.
8. Lou H, Jing X, Ren D, Wei X, Zhang X. Eriodictyol protects against 
H(2)O(2)-induced neuron-like PC12 cell death through activation of 
Nrf2/ARE signaling pathway. Neurochem Int 2012;61(2):251-7.
9. Kim MJ, Yun HS, Hong EH, Lee SJ, Baek JH, Lee CW, et al. 
Depletion of end-binding protein 1 (EB1) promotes apoptosis 
of human non-small-cell lung cancer cells via reactive oxygen 
species and Bax-mediated mitochondrial dysfunction. Cancer Lett 
2013;339(1):15-24.
10. Harms KL, Chen X. The C terminus of p53 family proteins is a cell fate 
determinant. Mol Cell Biol 2005;25(5):2014-30.
11. De Grandis V, Bizzarri AR, Cannistraro S. Docking study and free 
energy simulation of the complex between p53 DNA-binding domain 
and azurin. J Mol Recognit 2007;20(4):215-26.
12. Janouskova H, Ray AM, Noulet F, Lelong-Rebel I, Choulier L, 
Schaffner F, et al. Activation of p53 pathway by Nutlin-3a inhibits the 
expression of the therapeutic target a5 integrin in colon cancer cells. 
Cancer Lett 2013;336(2):307-18.
13. Jourdan M, Reme T, Goldschmidt H, Fiol G, Pantesco V, De Vos J, 
et al. Gene expression of anti - And pro-apoptotic proteins in malignant 
and normal plasma cells. Br J Haematol 2009;145(1):45-58.
14. Shipra G, Gauri M, Chandra PM, Kishore SP. Identification of novel 
potent inhibitors against Bcl-xL anti-apoptotic protein using docking 
studies. Protein Pept Lett 2012;19(12):1302-17.
15. Li SZ, Zhang HH, Zhang JN, Zhang ZY, Zhang XF, Zhang XD, 
et al. ALLN hinders HCT116 tumor growth through Bax-dependent 
apoptosis. Biochem Biophys Res Commun 2013;437(2):325-30.
16. Hu T, Wang L, Zhang L, Lu L, Shen J, Chan RL, et al. Sensitivity 
of apoptosis-resistant colon cancer cells to tanshinones is mediated by 
autophagic cell death and p53-independent cytotoxicity. Phytomedicine 
2015;22(5):536-44.
17. Dong GZ, Lee SY, Zhao HY, Lee YI, Jeong JH, Jeon R, et al. 
Fig. 3: Root‑mean‑square deviation difference from lower binding 
and upper binding energies of eriodictyol with p53, caspase 
8, B‑cell lymphoma‑2 (Bcl‑2), Bcl‑2 ‑ associated X protein, and 
adenomatous polyposis coli
Fig. 2: Structural‑based docking of identifying compounds of eriodictyol with proteins. Eriodictyol docked with different types of proteins 
such as (a) p53, (b) caspase 8, (c) B‑cell lymphoma‑2, (d) Bcl‑2 ‑ associated X protein, and (e) adenomatous polyposis coli. The residues 




Asian J Pharm Clin Res, Vol 10, Issue 1, 2017, 223-226
 Palani et al. 
226
Diarylheptanoids from lesser galangal suppress human colon cancer 
cell growth through modulating Wnt/β-catenin pathway. J Funct Foods 
2015;18:47-57.
18. Cristofaro M, Contursi A, D’Amore S, Martelli N, Spaziante AF, 
Moschetta A, et al. Adenomatous polyposis coli (APC)-induced 
apoptosis of HT29 colorectal cancer cells depends on mitochondrial 
oxidative metabolism. Biochim Biophys Acta 2015;1852(9):1719-28.
19. Kim JH, Kim YH, Song GY, Kim DE, Jeong YJ, Liu KH, et al. Ursolic 
acid and its natural derivative corosolic acid suppress the proliferation 
of APC-mutated colon cancer cells through promotion of β-catenin 
degradation. Food Chem Toxicol 2014;67:87-95.
20. Dow LE, O’Rourke KP, Simon J, Tschaharganeh DF, van Es JH, 
Clevers H, et al. Apc restoration promotes cellular differentiation 
and reestablishes crypt homeostasis in colorectal cancer. Cell 
2015;161(7):1539-52.
21. Lengauer T, Rarey M. Computational methods for biomolecular 
docking. Curr Opin Struct Biol 1996;6(3):402-6.
22. Trott O, Olson AJ. AutoDock Vina: Improving the speed and accuracy 
of docking with a new scoring function, efficient optimization, and 
multithreading. J Comput Chem 2010;31(2):455-61.
23. Jung IP, Cho JH, Koo BS, Yoon MY. Functional evaluation of 
residues in the herbicide-binding site of Mycobacterium tuberculosis 
acetohydroxyacid synthase by site-directed mutagenesis. Enzyme 
Microb Technol 2015;78:18-26.
24. Ren W, Truong TM, Ai HW. Study of the binding energies between 
unnatural amino acids and engineered orthogonal tyrosyl-tRNA 
synthetases. Sci Rep 2015;5:12632.
25. Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring 
in virtual screening for drug discovery: Methods and applications. Nat 
Rev Drug Discov 2004;3(11):935-49.
26. Ranjan S, Dasgupta N, Chinnappan S, Ramalingam C, Kumar A. A novel 
approach to evaluate titanium dioxidenanoparticle–protein interaction 
through docking: An insight into mechanism of action. Proc Natl Acad 
Sci India B Biol Sci 2015;1-7. DOI: 10.1007/s40011-015-0673-z.
27. Jha AN, Vishveshwara S, Banavar JR. Amino acid interaction 
preferences in proteins. Protein Sci 2010;19(3):603-16.
28. Kyte J, Doolittle RF. A simple method for displaying the hydropathic 
character of a protein. J Mol Biol 1982;157(1):105-32.
29. Feinstein WP, Brylinski M. Calculating an optimal box size for ligand 
docking and virtual screening against experimental and predicted 
binding pockets. J Cheminform 2015;7:18.
30. Alhossary A, Handoko SD, Mu Y, Kwoh CK. Fast, accurate, and 
reliable molecular docking with QuickVina 2. Bioinformatics 
2015;31(13):2214-6.
